Pyridostigmine Bromide
- Product NDC
- 47781-335
- 11-digit product format
- 477810335
- Labeler code
- 47781
- Product ID
- 47781-335_0429e410-7623-2f45-6170-d4a2eadd8742
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pyridostigmine Bromide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Alvogen, Inc.
- Application
- ANDA204737
- Marketing category
- ANDA
- Marketing start
- 2015-06-29
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pyridostigmine Bromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PYRIDOSTIGMINE BROMIDE | 180 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KVI301NA53 |
| Rxcui | 903847 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 47781-335-30 | Pyridostigmine Bromide | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 14 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 47781-335 | PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE [ALVOGEN, INC.] | 12 | Current NDC, Legacy NDC, 1 package rows | 20241012_93454159-0c58-1980-34b9-4038a2260420.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47781-335-30 | 47781033530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (47781-335-30) | 2015-06-29 | 0000-00-00 | No | No | Current |